Foster Dykema Cabot & Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$119K Hold
1,006
0.01% 140
2026
Q1
$120K Hold
1,006
0.01% 139
2025
Q4
$137K Hold
1,006
0.01% 143
2025
Q3
$148K Hold
1,006
0.01% 146
2025
Q2
$130K Hold
1,006
0.01% 149
2025
Q1
$120K Sell
1,006
-110
-10% -$13.6K 0.01% 151
2024
Q4
$129K Hold
1,116
0.01% 156
2024
Q3
$151K Sell
1,116
-66
-6% -$8.83K 0.01% 149
2024
Q2
$160K Buy
1,182
+66
+6% +$8.98K 0.01% 115
2024
Q1
$144K Buy
1,116
+110
+11% +$13.3K 0.01% 120
2023
Q4
$115K Buy
+1,006
New +$100K 0.01% 128

Other funds holding XYL

Foster Dykema Cabot & Partners's XYL Position: Q2 2026 in Review

Foster Dykema Cabot & Partners held its Xylem (XYL) position steady in Q2 2026 at 1,006 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #140.

Foster Dykema Cabot & Partners first reported a position in XYL in Q4 2023 and has held it in 11 quarters since. The position peaked at $160K in Q2 2024. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Foster Dykema Cabot & Partners held 1,006 shares of Xylem worth $119K as of Q2 2026.
  • Foster Dykema Cabot & Partners left its Xylem share count unchanged in Q2 2026.
  • Xylem made up 0.01% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #140 holding.
  • Foster Dykema Cabot & Partners first reported a position in Xylem in Q4 2023 and has held it in 11 quarters since.
  • Foster Dykema Cabot & Partners's Xylem position peaked at $160K in Q2 2024.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.